دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
What do we mean by complex percutaneous coronary intervention? An assessment of agreement amongst interventional cardiologists for defining complexity
Khaled Rjoob MSc, Victoria McGilligan PhD, Roisin McAllister PhD, Raymond Bond PhD, Gemina Doolub MBBS, MSc, Stephen J. Leslie FRCP, PhD, Matthew Manktelow PhD, Charles Knoery MBChB, James Shand FRCP, MD, Aleeha Iftikhar MSc, Anne McShane MSc, Mamas A. Mamas MB, BCh, PhD, Aaron Peace MB, BCh, PhD, EAPCI Innovation and Digital Cardiology Committee
doi : 10.1002/ccd.30684
In the last decade, percutaneous coronary intervention (PCI) has evolved toward the treatment of complex disease in patients with multiple comorbidities. Whilst there are several definitions of complexity, it is unclear whether there is agreement between cardiologists in classifying complexity of cases. Inconsistent identification of complex PCI can lead to significant variation in clinical decision-making.
Drug-coated balloon strategy following orbital atherectomy for calcified coronary artery compared with drug-eluting stent: One-year outcomes and optical coherence tomography assessment
Kentaro Mitsui MD, Tetsumin Lee MD, PhD, Ryoichi Miyazaki MD, Nobuhiro Hara MD, Sho Nagamine MD, PhD, Tomofumi Nakamura MD, PhD, Mao Terui MD, Shinichiro Okata MD, PhD, Masashi Nagase MD, Giichi Nitta MD, Keita Watanabe MD, Masakazu Kaneko MD, Yasutoshi Nagata MD, Toshihiro Nozato MD, PhD, Takashi Ashikaga MD, PhD, FJCC
doi : 10.1002/ccd.30689
Percutaneous coronary intervention (PCI) for calcified coronary artery remains challenging in the drug-eluting stent (DES) era. While recent studies reported the efficacy of orbital atherectomy (OA) combined with DES for calcified lesion, the effectiveness of drug-coated balloon (DCB) following OA has not been fully elucidated.
Predictors of bail-out stenting in patients with small vessel disease treated with drug-coated balloon percutaneous coronary intervention
Gabriele Ghetti MD, Francesco Bendandi MD, Francesco Donati MD, Leonardo Ciurlanti MD, Elena Nardi MStat, Antonio Giulio Bruno MD, Mateusz Orzalkiewicz MD, Tullio Palmerini MD, Francesco Saia MD, PhD, Cinzia Marrozzini MD, Nazzareno Galié MD, Nevio Taglieri MD
doi : 10.1002/ccd.30688
Drug-coated balloons (DCBs) have shown comparable results with drug-eluting stents in small vessel disease (SVD) percutaneous coronary intervention (PCI) in terms of target vessel revascularization and a reduced incidence of myocardial infarction. However, the relatively high rate of bail-out stenting (BOS) still represents a major drawback of DCB PCI.
Optical coherence tomography-derived predictors of stent expansion in calcified lesions
Annemieke C. Ziedses des Plantes BSc, Alessandra Scoccia MD, Tara Neleman BSc, Frederik T. W. Groenland MD, Laurens J. C. van Zandvoort MD, PhD, Jurgen M. R. Ligthart RT, Karen T. Witberg RN, Shengnan Liu PhD, Eric Boersma PhD, Rutger-Jan Nuis MD, PhD, Wijnand K. den Dekker MD, PhD, Jeroen Wilschut MD, Roberto Diletti MD, PhD, Felix Zijlstra MD, PhD, Nicolas M. Van Mieghem MD, PhD, Joost Daemen MD, PhD
doi : 10.1002/ccd.30687
Severe coronary artery calcification is associated with stent underexpansion and subsequent stent failure.
Quantitative flow ratio modulated by intracoronary optical coherence tomography for predicting physiological efficacy of percutaneous coronary intervention
Daixin Ding MSc, Shengxian Tu PhD, Yingguang Li PhD, Chunming Li BSc, Wei Yu PhD, Xun Liu MSc, Antonio Maria Leone MD, PhD, Cristina Aurigemma MD, Enrico Romagnoli MD, PhD, Rocco Vergallo MD, PhD, Carlo Trani MD, PhD, William Wijns MD, PhD, Francesco Burzotta MD, PhD
doi : 10.1002/ccd.30681
The combination of coronary imaging assessment and blood flow perturbation estimation has the potential to improve percutaneous coronary intervention (PCI) guidance.
Utility of optical coherence tomography in acute coronary syndromes
Keyvan Karimi Galougahi MD, PhD, Ali Dakroub MD, Karen Chau DO, Rony Mathew MD, Ajit Mullasari MD, Balbir Singh MD, Gunasekaran Sengottuvelu MBBS, Akiko Maehara MD, Gary Mintz MD, Allen Jeremias MD, Evan Shlofmitz DO, Nick E. J. West MD, Richard Shlofmitz MD, Ziad A. Ali MD, DPhil
doi : 10.1002/ccd.30656
Studies utilizing intravascular imaging have replicated the findings of histopathological studies, identifying the most common substrates for acute coronary syndromes (ACS) as plaque rupture, erosion, and calcified nodule, with spontaneous coronary artery dissection, coronary artery spasm, and coronary embolism constituting the less common etiologies.
Aortocoronary dissection during percutaneous coronary interventions for chronic total occlusion: Insights from the PROGRESS-CTO registry
Spyridon Kostantinis MD, Athanasios Rempakos MD, Bahadir Simsek MD, Judit Karacsonyi MD, PhD, Salman S. Allana MD, Khaldoon Alaswad MD, Mir Babar Basir MD, Oleg Krestyaninov MD, Dmitrii Khelimskii MD, Sevket Gorgulu MD, Rhian E. Davies DO, Stewart M. Benton Jr. MD, Jaikirshan J. Khatri MD, Paul Poommipanit MD, James W. Choi MD, Wissam A. Jaber MD, Stephane Rinfret MD, William Nicholson MD, Nazif Aygul MD, Bulent Behlul Altunkeser MD, Ahmed M. ElGuindy MD, Nidal Abi Rafeh MD, Omer Goktekin MD, Olga C. Mastrodemos BA, Bavana V. Rangan BDS, MPH, Yader Sandoval MD, M. Nicholas Burke MD, Emmanouil S. Brilakis MD, PhD
doi : 10.1002/ccd.30680
Aortocoronary dissection is a potentially serious complication of chronic total occlusion (CTO) percutaneous coronary intervention (PCI).
Retrograde percutaneous coronary intervention of chronic total occlusion via discontinuous septal channels
Yao-Jun Zhang MD, PhD, Wen-Rui Ma MSc, Bo Xu MBBS, Ze-Han Huang MSc, Xiao-Yong Zhang MD, Javaid Iqbal MD, PhD, Ke-Fei Dou MD, Christos V. Bourantas MD, PhD, Gerald S. Werner MD, PhD, Bin Zhang MD, PhD
doi : 10.1002/ccd.30678
The study aims to investigate the safety and feasibility of retrograde CTO intervention via collateral connection grade 0 (CC-0) septal channel and to identify predictors of collateral tracking failure.
Effectiveness, safety, and patient reported outcomes of a planned investment procedure in higher-risk chronic total occlusion percutaneous coronary intervention:Â Rationale and design of the invest-CTO study
Anja Øksnes MD, Elisabeth Skaar PhD, Britt Engan MD, Ã˜yvind Bleie PhD, Kjetil H. Løland PhD, Nadia Taoussi MD, Akiko Maheran PhD, Tone Merete NorekvÃ¥l PhD, Svein Rotevatn PhD, Margaret B. McEntegart PhD
doi : 10.1002/ccd.30692
The anatomical complexity of a chronic total occlusion (CTO) correlates with procedural failure and complication rates. CTO modification after unsuccessful crossing has been associated with subsequent higher technical success rates, but complication rates remain high with this approach.
A machine learning algorithm to predict a culprit lesion after out of hospital cardiac arrest
Nilesh Pareek MA, MRCP, PhD, Christopher Frohmaier PhD, Mathew Smith PhD, Peter Kordis, Antonio Cannata MD, MD, Jo Nevett Bsc, Rachael Fothergill PhD, Robert C. Nichol, Mark Sullivan, Nicholas Sunderland MA, BMBCh, MRCP, Thomas W. Johnson, Marko Noc, Jonathan Byrne Bsc, PhD, FRCP, Philip MacCarthy Bsc, PhD, FRCP, Ajay M. Shah MD, FRCP
doi : 10.1002/ccd.30677
We aimed to develop a machine learning algorithm to predict the presence of a culprit lesion in patients with out-of-hospital cardiac arrest (OHCA).
Comparison of quantitative flow ratio with instantaneous wave-free ratio and resting full-cycle ratio during daily routine in the catheterization laboratory
Jannis Stader, Marios Antoniadis MD, Matti Ussat MD, Rolf Wachter MD, Daniel Lavall MD, Michael Metze MD, Martin Neef MD, Christian Spies MD, Ulrich Laufs MD, Karsten Lenk MD
doi : 10.1002/ccd.30690
Quantitative flow ratio (QFR) is a novel, software-based method to evaluate the physiology of coronary lesions. The aim of this study was to compare QFR with the established invasive measurements of coronary blood flow using instantaneous wave-free ratio (iFR) or resting full-cycle ratio (RFR) in daily cathlab routine.
Anemia and periprocedural complications determine contrast-associated acute kidney injury after recanalization of chronic coronary occlusions in chronic kidney disease
Gerald S. Werner MD, PhD, FESC, FSCAI, Simon Lorenz MD, Zisis Dimitriadis MD, PhD, Bernd Krueger MD, PhD
doi : 10.1002/ccd.30685
Contrast-associated acute kidney injury (CA-AKI) is a potential risk associated with the percutaneous coronary interventions (PCI) for chronic total coronary occlusions (CTO) particularly with pre-existing chronic kidney disease (CKD). The determinants of CA-AKI in patients with pre-existing CKD in an era of advanced strategies of CTO recanalization techniques need to be considered for a risk evaluation of the procedure.
The contemporary role of protamine in the cardiac catheterization laboratory
Barbara A. Danek MD, Kathleen E. Kearney MD, Christine J. Chung MD, Zachary Steinberg MD, William L. Lombardi MD, James M. McCabe MD, Lorenzo Azzalini MD, PhD, MSc
doi : 10.1002/ccd.30679
Access to the arterial circulation and full anticoagulation carries a risk of serious bleeding during and after percutaneous coronary intervention. Important sources of bleeding include the arterial access site and coronary artery perforation.
Percutaneous treatment of left circumflex coronary artery injury related to mitral valve surgery: Case series and systematic review of the literature
Alice Benedetti MD, Gianluca Castaldi MD, Enrico Poletti MD, Alice Moroni MD, Benjamin Scott MD, Carl Convens MD, Stefan Verheye MD, PhD, Paul Vermeersch MD, PhD, Pierfrancesco Agostoni MD, PhD, Carlo Zivelonghi MD, PhD, MSc
doi : 10.1002/ccd.30693
Left circumflex coronary artery (LCx) injury related to mitral valve surgery is a rare complication. The best treatment option is not defined, and percutaneous coronary intervention (PCI) may represent an effective treatment to avoid prolonged myocardial ischemia.Â
Transcatheter edge-to-edge mitral valve repair for post-myocardial infarction papillary muscle rupture and acute heart failure: AÂ systematic review
Filippo Calì MD, Matteo Pagnesi MD, Elisa Pezzola MD, Andrea Montisci MD, Marco Metra MD, Marianna Adamo MD
doi : 10.1002/ccd.30682
Papillary muscle rupture (PMR) is a rare complication of acute myocardial infarction (AMI) associated with high mortality and morbidity. Surgery is the gold-standard treatment for these patients, but it is burdened by a high perioperative risk due to hemodynamic instability.
Three-year outcomes for transcatheter repair in patients with mitral regurgitation from the CLASP study
Konstantinos Spargias MD, D. Scott Lim MD, Raj Makkar MD, Saibal Kar MD, Robert M. Kipperman MD, William W. O′Neill MD, Martin K. C. Ng MBBS, PhD, Robert L. Smith MD, Neil P. Fam MD, Michael J. Rinaldi MD, Christopher O. Raffel MBBS, Darren L. Walters MBBS, Justin Levisay MD, Matteo Montorfano MD, Azeem Latib MD, John D. Carroll MD, Georg Nickenig MD, Stephan Windecker MD, Leo Marcoff MD, Gideon N. Cohen MD, Ulrich Schäfer MD, John G. Webb MD, Molly Szerlip MD
doi : 10.1002/ccd.30686
Mitral valve transcatheter edge-to-edge repair (M-TEER) is an effective option for treatment of mitral regurgitation (MR). We previously reported favorable 2-year outcomes for the PASCAL transcatheter valve repair system.
Intracardiac echocardiogram to diagnose infective endocarditis after transcatheter aortic valve-in-valve implantation
Cheuk Bong Ho MBBS, Niels G. Vejlstrup MD, PhD, Ole De Backer MD, PhD, Lars Søndergaard MD, DMSc
doi : 10.1002/ccd.30694
A 70-year-old man with history of transcatheter aortic valve-in-valve implantation was admitted because of suspected infective endocarditis (IE). Transesophageal echocardiogram did not reveal any vegetations, as the metallic stent frames caused significant artifacts.
The impact of moderate aortic stenosis in acute myocardial infarction: A multicenter retrospective study
Bishoy Abraham MD, Juan M. Farina MD, Ayman Fath MD, Merna Abdou MD, Mostafa Elbanna MD, Mustafa Suppah MD, Mohamed Sleem MD, Abdullah Eldaly MD, Mohamed Aly MD, Michael Megaly MD, Pradyumna Agasthi MD, Chieh-Ju Chao MD, David Fortuin MD, Said Alsidawi MD, Chadi Ayoub MD, Mohamad Alkhouli MD, Abdallah El Sabbagh MD, David Holmes Jr, MD, Emmanouil S. Brilakis MD, PhD, Reza Arsanjani MD
doi : 10.1002/ccd.30676
Aortic stenosis (AS) is associated with myocardial ischemia through different mechanisms and may impair coronary arterial flow. However, data on the impact of moderate AS in patients with acute myocardial infarction (MI) is limited.
Mild aortic insufficiency following transcatheter aortic valve replacement: A systematic review and meta-analysis
Irbaz Hameed MD, Adham Ahmed BS, Ashish Kumar MD, Eric Li BS, Katherine Candelario MD, Sumera Khan MD, Amudhan Kannan MD, Nida Latif MD, Andrea Amabile MD, Arnar Geirsson MD, Matthew L. Williams MD
doi : 10.1002/ccd.30674
Post-procedural aortic insufficiency (AI) continues to be prevalent following transcatheter aortic valve replacement (TAVR). While several studies have assessed the outcomes of moderate-severe AI following TAVR, the incidence, predictors, and outcomes of mild AI remain unclear.
Dental screening prior to transcatheter versus surgical aortic valve replacement: International Survey of Current Practices
Anthony J. Buckley MB, BCh, BAO, Mark Hensey MB, BCh, BAO, Stephen O'Connor MD, Andrew Maree MB, MSc, PhD
doi : 10.1002/ccd.30675
